Medical Care Technologies Inc. Moves Into Apple's Final TestFlight Testing Phase for Its Debut Consumer AI App
Medical Care Technologies (OTC PINK: MDCE) announced on December 1, 2025 that its first consumer AI mobile application has entered Apple iOS TestFlight, described as the final testing phase before App Store release.
Rhea-AI Summary
Medical Care Technologies (OTC PINK: MDCE) announced on December 1, 2025 that its first consumer AI mobile application has entered Apple iOS TestFlight, described as the final testing phase before App Store release. The app targets a $13.4 billion global health and nutrition app market and represents MDCE's first major consumer product outside its medical roadmap.
The company plans a sequential rollout: complete iOS TestFlight, obtain App Store approval and launch iOS, begin Google Play testing, then pursue a global Android launch after Google approval. Management said the app showcases internal development and AI capabilities and that a leading marketing agency will be engaged at launch. MDCE will provide ongoing investor updates as testing and feature refinement continue.
Positive
- None.
Negative
- None.
Details
News Market Reaction – MDCE
On Dec 1, the day this news came out, MDCE closed 25.00% below the previous close.
Data tracked by StockTitan Argus for the Dec 1 session.
Key Figures
- Health & nutrition app market
- $13.4 billion
- Worldwide health & nutrition app market targeted by MDCE’s first AI platform
- Authenticated premium items
- 100+ items
- Real Game Used authenticated more than 100 premium items in 30 days
- Potential item value
- Just over $10 million
- Combined potential value of items authenticated by Real Game Used
- YTD subsidiary revenue
- $848,987
- Year-to-date revenue reported for subsidiaries as of Nov 24, 2025
- Q3 revenue
- $478,218
- Q3 revenue contribution from subsidiaries noted on Nov 24, 2025
- Global chronic wound burden
- 50 million+ people
- Chronic wounds cited as affecting 50M+ people globally
- Melanoma early-detection survival
- Up to 99%
- Claimed survival rate when melanoma is detected early
- Diet & nutrition app market
- USD 2.14B to 4.56B
- Global diet & nutrition apps market from 2024 to 2030 cited in prior AI release
Historical Context
-
Subsidiary Real Game Used validated AI-based sports memorabilia authentication scale.
-
Share structure stabilization and new tech partnership with AI health tools focus.
-
Integration of Google-backed Derm Foundation into skin and wound monitoring app.
-
Conclusion of Reg A offering and shift toward 2026 AI product and revenue expansion.
-
Strategic acceleration toward AI health, nutrition, wellness, and food intelligence apps.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
"MDCE Aims at a
MESA, ARIZONA / ACCESS Newswire / December 1, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) is pleased to announce that its first consumer-based mobile application-designed to showcase the company's expanding technological capabilities-is now deep into Apple's iOS TestFlight testing phase, the final stage before public release on the App Store.
This artificial-intelligence-powered application introduces a unique twist within the global multi-billion-dollar food and cuisine mobile app sector, representing MDCE's first major step into mass-market consumer technology. The company will reveal the official name of the application upon launch, and MDCE is preparing to engage a leading marketing agency specializing in worldwide mobile app releases.
"Reaching the TestFlight milestone demonstrates the strength of our internal development team," said Marshall Perkins III, CEO of Medical Care Technologies Inc. "This first consumer application is a testament to our coding expertise and early AI capabilities. We believe it will have the potential to generate revenue in several countries as we continue to build an expanding library of AI-driven applications set for release over the coming quarters."
MDCE's development roadmap includes the following sequential steps:
Complete the iOS TestFlight evaluation;
Obtain Apple App Store approval and launch the iOS version;
Immediately begin the Google Play testing phase;
Upon Google's approval, proceed with the official global Android launch.
The company will continue providing regular updates to investors regarding the status of both its consumer-focused AI application and its upcoming AI-based medical applications as testing progresses and features are refined.
About Medical Care Technologies Inc. (MDCE)
Medical Care Technologies Inc. (OTC PINK: MDCE) is an emerging technology company focused on developing artificial intelligence-based applications across health, consumer, and enterprise sectors. Leveraging advanced computer vision, machine learning, and mobile software architecture, MDCE builds scalable digital products with global commercial potential. The company is headquartered in Mesa, Arizona. For more information, please visit www.medicalcaretechnologies.com.
Safe Harbor Statement
This press release contains forward-looking statements based on current expectations and assumptions. Actual results may differ due to risks and uncertainties related to regulatory approvals, market conditions, product performance, and operational factors. The company undertakes no obligation to update such statements except as required by law.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.